Cardiac Rehabilitation Increases SIRT1 Activity and β-Hydroxybutyrate Levels and Decreases Oxidative Stress in Patients with HF with Preserved Ejection Fraction
Table 1
Main characteristics of total population and ET-CR group at baseline.
Variables
Total population
Ctr
ET-CR
Age (years),
0.357
BMI (kg/m2),
0.154
SBP (mmHg),
0.443
DBP (mmHg),
0.511
EF (%),
0.117
LVEDD (mm)
0.404
CAD, (%)
14 (71.4)
14 (70)
36 (72)
0.542
PTCA, (%)
37 (52.9)
11 (55)
26 (52)
0.516
CABG, (%)
10 (14.3)
3 (15)
7 (14)
0.59
Previous IMA, (%)
47 (67.1)
13 (65)
(68)
0.51
Valvular substitution, (%)
3 (4.3)
1 (5)
2 (4)
0.642
Smoking, (%)
37 (52.9)
9 (45)
28 (56)
0.285
Hypertension, (%)
30 (42.9)
8 (40)
22 (44)
0.487
Dislipidemia, (%)
31 (44.3)
9 (45)
22 (44)
0.574
Diabetes, (%)
14 (20)
4 (20)
10 (20)
0.619
COPD, (%)
13 (18.6)
4 (20)
9 (18)
0.545
Beta blockers
64 (91.4)
18 (90)
46 (92)
0.556
ACE inhibitors
32 (45.7)
9 (45)
23 (46)
0.576
ARBs
9 (12.9)
2 (10)
7 (14)
0.495
Diuretics
20 (28.6)
5 (25)
15 (30)
0.458
Ca2 antagonists
7 (10)
2 (10)
5 (10)
0.652
Aspirin
56 (80)
15 (75)
41 (82)
0.361
Anticoagulants
33 (47.1)
9 (45)
24 (48)
0.516
Oral hypoglycemics
11 (15.7)
4 (20)
7 (14)
0.385
Insulin
5 (7.1)
1 (5)
4 (8)
0.556
Statin
53 (75.7)
15 (75)
38 (76)
0.578
Data are expressed as the or number of subjects (%). BMI: body mass index; SBP: systolic blood pressure; DPB: diastolic blood pressure; EF: ejection fraction; LVEDD: left end diastolic diameter; CAD: coronary artery disease; PTCA: percutaneous transluminal coronary angioplasty; CABG: coronary artery bypass graft; COPD: chronic obstructive pulmonary disease; ARBs: angiotensin II receptor blockers.
